CISLIEVA 10 MG Injection (Cisplatin): A Fundamental Platinum-Based Therapy for Precision Oncology CISLIEVA 10 MG Injection is a highly potent antineoplastic agent featuring the active pharmaceutical ingredient Cisplatin. As a first-generation platinum-based chemotherapeutic agent, Cisplatin remains one of the most effective and widely utilized drugs in the global fight against various solid tumors.. The 10mg dosage is a critical strength used for precise titration, allowing oncologists to design customized treatment cycles that balance therapeutic efficacy with patient safety. Therapeutic Indications and Clinical Scope Metastatic Testicular Tumors: A primary component of combination therapy in patients who have already received appropriate surgical or radiotherapeutic procedures. Metastatic Ovarian Tumors: Indicated as secondary therapy in patients who have already received but failed standard chemotherapy, or as a first-line agent in combination with other approved drugs. Advanced Bladder Cancer: Used as a single agent or in combination for patients with transitional cell bladder cancer that is no longer amenable to local treatments. Head and Neck Cancers: Frequently employed in chemotherapy regimens for squamous cell carcinomas of the head and neck. Cervical Cancer: Used in conjunction with radiation therapy or other chemotherapeutic agents for advanced stages. Mechanism of Action: How CISLIEVA 10 MG Works Cellular Entry: Once the drug enters the cell, it loses its chloride atoms and becomes a positively charged molecule. DNA Binding: The activated platinum complex binds to the nitrogen atoms of the DNA bases (specifically guanine and adenine). Intrastand Cross-Linking: It creates “kinks“ or cross-links within the DNA strands. Inhibition of Synthesis: These structural changes make it impossible for the DNA to unwind or replicate. Programmed Cell Death: The DNA damage triggers a cellular response that leads to apoptosis (programmed cell death), halting tumor growth and preventing metastasis. Professional Administration and Safety Guidelines Route: Administered strictly via Intravenous (IV) Infusion. Hydration Protocol: To minimize the risk of nephrotoxicity (kidney damage), patients must receive adequate pre-treatment and post-treatment hydration (usually 1 to 2 liters of fluid). Clinical Environment: This medication must be administered by trained oncology professionals in a setting equipped for continuous monitoring. Precise Titration: The 10mg strength facilitates accurate dosing for pediatric cases or for patients requiring gradual dose escalation . Safety Profile and Professional Monitoring Nephrotoxicity Monitoring: Regular monitoring of serum creatinine, BUN, and creatinine clearance is mandatory. Ototoxicity Checks: Patients should undergo periodic hearing tests (audiograms), as Cisplatin can cause cumulative and permanent hearing loss. Hematological Vigilance: Regular Complete Blood Counts (CBC) are essential to monitor for bone marrow suppression (anemia, neutropenia, and thrombocytopenia). Electrolyte Balance: Monitoring of serum magnesium, potassium, and calcium levels is required to prevent imbalances. Neurotoxicity Monitoring: Vigilance for signs of peripheral neuropathy (numbness or tingling in extremities). Storage and Global Handling Instructions Temperature: Store at controlled room temperature (20°C to 25°C). Do not refrigerate or freeze, as precipitation may occur. Protection: Keep the vial in the original carton to protect it from light. Cytotoxic Handling: As a hazardous antineoplastic agent, CISLIEVA 10 MG must be prepared and handled by trained professionals using appropriate PPE (Personal Protective Equipment) and disposed of according to international biohazard protocols. Why Choose Ernest Oncology? 100% Genuine Medication: We source directly from GMP-certified channels, ensuring every vial is authentic with an optimal shelf life. Specialized Logistics Precision: Our team manages pharmaceutical exports with expertise, utilizing secure packaging and efficient transit routes to maintain product stability. Regulatory & Documentation Support: We handle all necessary paperwork, including Certificates of Analysis (CoA) and export permits, for seamless customs clearance. Bulk Supplier Advantage: As a dedicated distributor, we offer competitive wholesale rates to support oncology hospitals, pharmacy networks, and government health programs worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct WhatsApp Connection
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us
